Georgia Gardiner from Leeds faced misdiagnosis for months. Later, she discovered she had rare stomach cancer. The cancer had ...

Institut Curie researchers have identified a sex-specific molecular pathway connecting E-cadherin loss, estrogen receptor-α ...

CDH1: The gene encoding E-cadherin, a protein critical for cell adhesion; loss-of-function mutations in this gene are a leading cause of HDGC. Prophylactic Total Gastrectomy: ...

Among sequential patients with breast cancer, 10.7% were found to have a germline mutation in a gene that predisposes women to breast or ovarian cancer, using a panel of 25 predisposition genes.

Gene editing holds the potential of suppressing mosquito species that carry deadly diseases — and raises ethical questions.

Dr Namrata Singal Sawant, a Mumbai-based senior radiologist, explains why more young women are getting diagnosed with breast ...

Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further innovations in safety, efficacy, and treatment strategies are needed.

Leaders from the world of cell and gene therapy, including molecular geneticists, immunotherapists, physicians, nonprofit directors, and patient advocates, shared their personal stories and policy ...

Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and speed of new drug approvals.

Nine-month-old KJ Muldoon is the first patient to successfully receive personalized CRISPR gene editing therapy. After 300 days in the hospital, baby KJ has returned home.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Intellia's technology platform specializes in Clustered Regularly Interspaced Short ...